Trial NCT04754815

View at ClinicalTrials.gov 
Org. Study IDs: HFHS 21-01

Last trial update was posted on 2022-03-29

MeSH Interventions

Albumin-Bound Paclitaxel Paclitaxel Pembrolizumab Pemetrexed

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Advanced Lung Non-Small Cell Carcinoma Non Small Cell Lung Cancer PD-L1 Gene Mutation

Stopping Reasons

Logistical challenges primarily due to COVID led to delay in starting the study and now is not felt to be clinically relevant.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID